The present invention relates to methods and reagents for drug screening. Screening methods are disclosed employing neuronal cells that have been treated so as to exhibit characteristics associated with a re-entry into the cell cycle. One treatment approach comprises transfection of neuronal cells with an expression vector comprising one or more oncogenes.

 
Web www.patentalert.com

< Promoter and plasmid system for genetic engineering

> Recombinant adeno-associated virus production

> Definitive endoderm

~ 00509